185 related articles for article (PubMed ID: 29416771)
1. Menopause and adipose tissue: miR-19a-3p is sensitive to hormonal replacement.
Kangas R; Morsiani C; Pizza G; Lanzarini C; Aukee P; Kaprio J; Sipilä S; Franceschi C; Kovanen V; Laakkonen EK; Capri M
Oncotarget; 2018 Jan; 9(2):2279-2294. PubMed ID: 29416771
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs.
Olivieri F; Ahtiainen M; Lazzarini R; Pöllänen E; Capri M; Lorenzi M; Fulgenzi G; Albertini MC; Salvioli S; Alen MJ; Kujala UM; Borghetti G; Babini L; Kaprio J; Sipilä S; Franceschi C; Kovanen V; Procopio AD
Aging Cell; 2014 Oct; 13(5):850-61. PubMed ID: 25040542
[TBL] [Abstract][Full Text] [Related]
3. Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy.
Kangas R; Törmäkangas T; Fey V; Pursiheimo J; Miinalainen I; Alen M; Kaprio J; Sipilä S; Säämänen AM; Kovanen V; Laakkonen EK
Sci Rep; 2017 Feb; 7():42702. PubMed ID: 28195143
[TBL] [Abstract][Full Text] [Related]
4. Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy--a study with monozygotic twin pairs.
Kangas R; Pöllänen E; Rippo MR; Lanzarini C; Prattichizzo F; Niskala P; Jylhävä J; Sipilä S; Kaprio J; Procopio AD; Capri M; Franceschi C; Olivieri F; Kovanen V
Mech Ageing Dev; 2014 Dec; 143-144():1-8. PubMed ID: 25448133
[TBL] [Abstract][Full Text] [Related]
5. Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women.
Ahtiainen M; Pöllänen E; Ronkainen PH; Alen M; Puolakka J; Kaprio J; Sipilä S; Kovanen V
Age (Dordr); 2012 Oct; 34(5):1249-60. PubMed ID: 21845403
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-19a-3p and miR-19b-3p characterize the human aging process and their isomiRs associate with healthy status at extreme ages.
Morsiani C; Terlecki-Zaniewicz L; Skalicky S; Bacalini MG; Collura S; Conte M; Sevini F; Garagnani P; Salvioli S; Hackl M; Grillari J; Franceschi C; Capri M
Aging Cell; 2021 Jul; 20(7):e13409. PubMed ID: 34160893
[TBL] [Abstract][Full Text] [Related]
7. Effect of miR-18a-5p, miR-19a-3p, and miR-20a-5p on
Maleki B; Noureddini M; Saadat S; Verdi J; Farrokhian A; Ghanbarian H; Cheraghi E; Alani B
Rep Biochem Mol Biol; 2023 Apr; 12(1):136-146. PubMed ID: 37724150
[TBL] [Abstract][Full Text] [Related]
8. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
Gower BA; Nagy TR; Goran MI; Smith A; Kent E
J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
[TBL] [Abstract][Full Text] [Related]
9. Age- and menopause-related differences in subcutaneous adipose tissue estrogen receptor mRNA expression.
Park YM; Erickson C; Bessesen D; Van Pelt RE; Cox-York K
Steroids; 2017 May; 121():17-21. PubMed ID: 28288896
[TBL] [Abstract][Full Text] [Related]
10. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulation of Estrogen Receptor Genes' Expressions in Adipose Tissue in the Course of Obesity.
Koźniewski K; Wąsowski M; Jonas MI; Lisik W; Jonas M; Binda A; Jaworski P; Tarnowski W; Noszczyk B; Puzianowska-Kuźnicka M; Kuryłowicz A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682668
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy.
Perrone G; Liu Y; Capri O; Critelli C; Barillaro F; Galoppi P; Zichella L
Gynecol Obstet Invest; 1999; 48(1):52-5. PubMed ID: 10394093
[TBL] [Abstract][Full Text] [Related]
13. miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis.
Chen K; He H; Xie Y; Zhao L; Zhao S; Wan X; Yang W; Mo Z
Sci Rep; 2015 Jul; 5():11909. PubMed ID: 26148871
[TBL] [Abstract][Full Text] [Related]
14. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
15. Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use.
Gower BA; Muñoz J; Desmond R; Hilario-Hailey T; Jiao X
Obesity (Silver Spring); 2006 Jun; 14(6):1046-55. PubMed ID: 16861610
[TBL] [Abstract][Full Text] [Related]
16. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
Sites CK; Brochu M; Tchernof A; Poehlman ET
Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
[TBL] [Abstract][Full Text] [Related]
17. Plasma exosome-derived microRNAs expression profiling and bioinformatics analysis under cross-talk between increased low-density lipoprotein cholesterol level and ATP-sensitive potassium channels variant rs1799858.
Liu C; Lai Y; Ying S; Zhan J; Shen Y
J Transl Med; 2020 Dec; 18(1):459. PubMed ID: 33272292
[TBL] [Abstract][Full Text] [Related]
18. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.
Coban N; Erkan AF; Ozuynuk-Ertugrul AS; Ekici B
Acta Cardiol; 2023 Oct; 78(8):945-956. PubMed ID: 37376990
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels.
Sandrim VC; Luizon MR; Palei AC; Tanus-Santos JE; Cavalli RC
BJOG; 2016 Dec; 123(13):2120-2128. PubMed ID: 26853698
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
